METALK

Development of a novel tandem ring closing metathesis process as a general route to the first syntheses of various lycorine type alkaloids

 Coordinatore UNIVERSITE JOSEPH FOURIER GRENOBLE 1 

 Organization address address: "Avenue Centrale, Domaine Universitaire 621"
city: GRENOBLE
postcode: 38041

contact info
Titolo: Mr.
Nome: Yann
Cognome: Le Roux
Email: send email
Telefono: +33 4 76 514488
Fax: +33 4 76 63 59 56

 Nazionalità Coordinatore France [FR]
 Totale costo 193˙594 €
 EC contributo 193˙594 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2011-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-09-01   -   2014-08-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITE JOSEPH FOURIER GRENOBLE 1

 Organization address address: "Avenue Centrale, Domaine Universitaire 621"
city: GRENOBLE
postcode: 38041

contact info
Titolo: Mr.
Nome: Yann
Cognome: Le Roux
Email: send email
Telefono: +33 4 76 514488
Fax: +33 4 76 63 59 56

FR (GRENOBLE) coordinator 193˙594.80

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

metalk    significant    alkaloids    toward    full    cancer    modes    family    variety    chemical    synthetic    area    biological    natural    lycorine    analogues    action    synthesis    source    derivatives    methodology    efficient    date    drugs    crucial   

 Obiettivo del progetto (Objective)

'Cancer is the leading cause of death worldwide and therefore a continued need exists for new drugs with new modes of action. To date, over 60% of drugs employed to target cancer are natural product derived or inspired and this places significant importance on research into the total synthesis of natural products. It also supports the need for the “next generation” of researchers to receive training in this area in order to enable the EU to remain globally competitive. The lycorine family of natural products have shown promise for the development of novel drugs; however a full study requires general access to these alkaloids. We propose a research project to develop methodology for the first syntheses of these complex natural products and novel derivatives, in order to enable future biological testing. For an efficient synthesis of these compounds, we envisage the development of a novel tandem RCM sequence, which can afford, in a single event, a decorated tetrahydroindole skeleton bearing an enol ether, which is crucial to the post-functionalisation of the bicycle. This methodology would allow a straightforward and selective synthesis of numerous lycorine alkaloids not synthesised to date. We also propose to explore the benefits of using Flow Chemistry, in particular to extend the methodology to more sensitive substrates. This is a rapidly expanding and exciting area of research, and dissemination of this knowledge within Europe in the near future is important. This proposal also offers the opportunity to establish future collaborations in this area, strengthening EU competitiveness. The applicant is an outstanding British female scientist and this fellowship would facilitate her pursuit of an independent academic career within the EU and her ability to become a future role model for women in science.'

Introduzione (Teaser)

Cancer treatment remains a significant medical challenge today and there is an urgent need for new drugs with novel modes of action. EU funding is enabling research in this area using synthetic lycorine-based products.

Descrizione progetto (Article)

Natural products based drugs are valuable source of drugs, and their structural diversity and mode of action helps to gain ground in the fight against various important diseases, including viral and bacterial infections as well as cancer. Lycorine type natural products are encountered in various forms of lilies that can be highly toxic if ingested in large quantities.

One of the known modes of actions of lycorine alkaloids is the inhibition of protein synthesis. However, exploration of the full repertoire of the biological activities of lycorine products is hampered by very low availability from naturals source of many alkaloids of this family and also due to the absence of efficient chemical synthesis.

The EU-funded METALK project proposed a novel methodology to enable an efficient chemical synthesis of these complex natural products and their derivatives for future biological testing. The synthetic approach should be flexible and versatile in order to obtain a variety of lycorine alkaloids, as well as analogues.

A particular imidate aldolization step has been explored and developed, using a Lewis acid to prevent the inherent reversibility of the reaction. This step generates a crucial precursor for the synthetic route toward lycorine alkaloids. Remarkably, this novel method also allowed accessing in enantiomerically pure form a neurotransmitter inhibitor in just four steps.

The METALK has enabled a crucial step toward the synthesis of a variety of lycorine alkaloids. It should now lead to the synthesis of many congeners and therefore to their comprehensive characterisation. It should be of particular interest to the pharmaceutical sector and facilitate the broad testing of lycorine products and analogues as drug candidates.

Altri progetti dello stesso programma (FP7-PEOPLE)

LISCOMF (2013)

Light-induced spatiotemporal control of membrane fusion for targeted therapy

Read More  

IGF1RHC (0)

Targeting IGF-1 receptor in liver cancer with focus on its mechanistic role in transcription and its interaction with the cell cycle machinery

Read More  

ENGAGES (2011)

ENtanglement renormalization and GAuGE Symmetry

Read More